Former Chief People Officer of OODA Health and Ginger Joins H1
Former Chief People Officer of OODA Health and Ginger Joins H1 Traunza Adams Joins H1 as Chief People Officer as...
Month: October 2021
Syapse Enters Real-World Data Collaboration with Merck to Inform and Improve Cancer Care
SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-word evidence company dedicated to extinguishing the fear and...
Chiesi USA Donates nearly $15,000 to Three Triangle Nonprofits through Partnership with Durham Bulls
Chiesi USA Durham Bulls Partnership Check Presentation Mike Wasyluk, Director of New Product Planning for Chiesi, presents the strikeout donations...
Daré Bioscience to Participate in Panel Discussion at DTC Perspectives’ Xpectives.Health Summit, October 12-14, 2021
An interactive conversation regarding the importance of industry and investor commitment to women’s health innovationSAN DIEGO, Oct. 06, 2021 (GLOBE...
Cocrystal Pharma Receives Australian Regulatory Clearance to Initiate Phase 1 Study of CC-42344 for the Treatment of Pandemic and Seasonal Influenza
BOTHELL, Wash., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology...
Pure Extracts Commencing Build-Out of Extraction Facility in Michigan
VANCOUVER, British Columbia, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
Resonant Inc. Expands Strategic Partnership with Murata Manufacturing Co., Ltd., the World’s Leading RF Module and Filter Provider
Resonant’s XBAR® Technology to be Leveraged Across Additional BandsAUSTIN, Texas, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN),...
Theratechnologies to Present at the H.C. Wainwright 5th Annual Nash Investor Conference
MONTREAL, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the...
Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Filing of New Drug Application for ACER-001 to Treat Urea Cycle Disorders
FDA sets PDUFA target action date of June 5, 2022NEWTON, Mass. and GENEVA, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Acer...
Cassava Sciences Initiates a Phase 3 Efficacy Trial of Simufilam for the Treatment of Patients with Alzheimer’s Disease
First Phase 3 Study is Initiated to Evaluate Safety and Efficacy of Simufilam Over 52 Weeks in 750 Patients with...
Entera Bio Presents Positive Phase 2 6-Month Bone Mineral Density Data for Oral PTH Formulation at Late Breaker ASBMR Conference Session
Increases in lumbar spine, femoral neck and total hip BMD demonstrated with EB613 Linear Dose Responses Seen in Biomarker and...
Acasti Pharma Awarded Composition-of-Matter Patents for GTX-101 in Europe, China and Mexico and for GTX-102 in Japan
Patents strengthen Acasti’s IP portfolio and provide protection through 2036 and 2037, respectivelyLAVAL, Québec, Oct. 06, 2021 (GLOBE NEWSWIRE) --...
PDS Biotechnology Welcomes Matthew Hill as Chief Financial Officer
FLORHAM PARK, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
Medolife Rx Initiates Comparative Study of Its Flagship CBD-based Muscle Rub and Competitor
Quanta, Inc. Figure 1.1 BURBANK, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a...
Syneos Health Acquires RxDataScience
Acquisition Delivers AI and Data Engineering Expertise, Enterprise Analytics and Technology-Enabled Solutions to Accelerate Customer PerformanceMORRISVILLE, N.C., Oct. 06, 2021...
Teladoc Health Reimagines Primary Care with Primary360
Teladoc Health Primary360 Teladoc Health Reimagines Primary Care with Primary360 New Primary Care Model Delivers Greater Care Access & Health...
Apexigen Announces First Patient Dosed in Phase 3 Pivotal Trial for BD0801, an Anti-VEGF Monoclonal Antibody, in Combination Therapy for Ovarian Cancer
- BD0801, discovered using Apexigen’s APXiMAB™ antibody technology platform, is in development by Simcere in China through a licensing agreement -SAN...
Alignment Healthcare Caters to Growing Hispanic Senior Community with Launch of the One, a $0 Premium Medicare Advantage Plan, for 2022
ORANGE, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare, a leading mission-based Medicare Advantage insurance company, will introduce the...
Assembly Bio Announces October Conference Participation
SOUTH SAN FRANCISCO, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing...
Elicio Therapeutics Announces First Patient Dosed in the ELI-002 (AMPLIFY-201) study in KRAS-Driven Cancers
The first patient was dosed at MD Anderson as part of a multicenter clinical trial to evaluate the safety and...
